Estrella Immunopharma Inc. Insider Trading
ESLA
No open-market buying or selling by insiders.
The last open-market buy by an executive or director was in Oct 2025.
Get an email when ESLA's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Sep 11, 2025 – Oct 7, 2025 | Jiandong Xu Chief Financial Officer | Bought 3 parts | 2,100 | $1.24 average | 3K | 0.7% | Form 4 |
- Sep 11, 2025 – Oct 7, 2025Jiandong XuChief Financial Officer · bought 2,100 at avg $1.243K0.7% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Biological Products, (No Diagnostic Substances) · Pick stocks to compare with ESLA
Spot a number that looks wrong? Check it in ESLA's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing ESLA
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.